Sestamibi
Sestamibi for the preparation of Tc99m Sestamibi injection)
Approved
Approval ID
5ef52f7c-042e-4f84-8048-5249bd01fade
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 23, 2012
Manufacturers
FDA
AnazaoHealth Corporation
DUNS: 011038762
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Sestamibi
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code51808-208
Product Classification
G
Generic Name
Sestamibi
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 13, 2012
FDA Product Classification
INGREDIENTS (5)
TRISODIUM CITRATE DIHYDRATEInactive
Quantity: 3.9 mg in 1 1
Code: B22547B95K
Classification: IACT
TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATEActive
Quantity: 1.5 mg in 1 1
Code: N6OU7HJ70P
Classification: ACTIB
MANNITOLInactive
Quantity: 30 mg in 1 1
Code: 3OWL53L36A
Classification: IACT
STANNOUS CHLORIDEInactive
Quantity: 0.112 mg in 1 1
Code: 1BQV3749L5
Classification: IACT
CYSTEINE HYDROCHLORIDEInactive
Quantity: 1.5 mg in 1 1
Code: ZT934N0X4W
Classification: IACT